$URGN news

The latest URGN stock news: headlines, filings, AI summaries and sentiment for $URGN, updated around the clock.

• UroGen Pharma Reports Strong Revenue Growth Driven by Zosturi Sales Motley Fool · November 4, 2026, 21:30 UTC
• UroGen Pharma Reports 35% Sequential Revenue Growth for ZUSDURI in Q3 2026 Seeking Alpha · November 4, 2026, 20:55 UTC
• UroGen Reports Significant Revenue Growth and Narrowing Losses in Q3 2026 Motley Fool · November 4, 2026, 19:54 UTC
• UroGen Pharma Ltd. - 10-Q Filing SEC EDGAR · November 4, 2026, 14:17 UTC
• UroGen Pharma Ltd. - 8-K Filing SEC EDGAR · November 4, 2026, 13:08 UTC
• UroGen Pharma Reports Q3 Earnings Miss on EPS and Revenue Seeking Alpha · November 4, 2026, 13:06 UTC
• UroGen's Commercial Performance and Pipeline Expansion Yahoo Finance · September 23, 2026, 13:13 UTC
• UroGen's Chief Medical Officer Sells $400K in Stock Following Significant Share Price Increase Yahoo Finance · July 12, 2026, 18:31 UTC
• UroGen's Chief Medical Officer Sells $400K in Stock Following Significant Share Price Increase Motley Fool · July 12, 2026, 18:11 UTC
• UroGen Pharma Ltd. - 8-K Filing SEC EDGAR · June 23, 2026, 20:14 UTC
• UroGen settles patent dispute with Teva over Jelmyto Seeking Alpha · June 2, 2026, 12:36 UTC
• UroGen Pharma Ltd. - 8-K Filing SEC EDGAR · June 2, 2026, 12:05 UTC
• Superstring Capital Sells $6.6M Stake in UroGen Pharma Amid Stock Surge Yahoo Finance · May 23, 2026, 22:40 UTC
• Superstring Capital Sells $6.6M Stake in UroGen After Stock Surges Over 600% Motley Fool · May 23, 2026, 22:20 UTC
• UroGen (URGN) Reports Q1 2026 Earnings with Strong Revenue Growth Motley Fool · May 7, 2026, 16:06 UTC